五家中国药企进入辉瑞新冠口服药“特仿”名单

105
9
Favorite

五家中国药企进入辉瑞新冠口服药“特仿”名单

老虎资讯综合2022-03-17

3月17日讯，日内瓦药品专利池（Medicines PatentPool, MPP）组织宣布，上海迪赛诺、华海药业、普洛药业、复星医药、九洲药业这五家中国药企进入辉瑞新冠口服药Paxlovid的“特仿”名单。在新冠疫情仍被定义为突发公共卫生事件期间，它们可以免专利费生产Paxlovid的核心成分奈玛特韦（nirmatrelvir）。其中，九洲药业仅生产原料药，另外4家可同时生产原料药和制剂。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

105

Report

Comment（9）

一分流水
·2022-03-18
事實證明是莊家喊我來接盤的。以後這樣的帖子假裝看不見。 [流淚]
Reply
2
Report
一分流水
·2022-03-18
今天要漲嗎？
Reply
4
Report
Yeong
·2022-03-18
Y
Reply
1
Report
winnieer
·2022-03-18
😊
Reply
Like
Report
Futre
·2022-03-18
贊👍
Reply
Like
Report
Youn7276
·2022-03-18
Ok
Reply
3
Report
年年虎
·2022-03-18
😐
Reply
2
Report
NCP88
·2022-03-18
好
Reply
2
Report
VinHun
·2022-03-17
[微笑] [開心] [財迷] [呆住] [呆住] [得意] [得意]
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1171059471?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","is_english":false,"pubTime":"2022-03-17 23:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171059471","market":"sh","top_or_hot":-1,"title":"五家中国药企进入辉瑞新冠口服药“特仿”名单","media":"老虎资讯综合","content":"<html><head></head><body><p>3月17日讯，日内瓦药品专利池（Medicines PatentPool, MPP）组织宣布，上海迪赛诺、<a href=\"https://laohu8.com/S/600521\">华海药业</a>、<a href=\"https://laohu8.com/S/000739\">普洛药业</a>、<a href=\"https://laohu8.com/S/600196\">复星医药</a>、<a href=\"https://laohu8.com/S/603456\">九洲药业</a>这五家中国药企进入<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>新冠口服药Paxlovid的“特仿”名单。在新冠疫情仍被定义为突发公共卫生事件期间，它们可以免专利费生产Paxlovid的核心成分奈玛特韦（nirmatrelvir）。其中，九洲药业仅生产原料药，另外4家可同时生产原料药和制剂。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>五家中国药企进入辉瑞新冠口服药“特仿”名单</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n五家中国药企进入辉瑞新冠口服药“特仿”名单\n</h2>\n\n<h4 class=\"meta\">\n\n2022-03-17 23:28 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月17日讯，日内瓦药品专利池（Medicines PatentPool, MPP）组织宣布，上海迪赛诺、华海药业、普洛药业、复星医药、九洲药业这五家中国药企进入辉瑞新冠口服药Paxlovid的“特仿”名单。在新冠疫情仍被定义为突发公共卫生事件期间，它们可以免专利费生产Paxlovid的核心成分奈玛特韦（nirmatrelvir）。其中，九洲药业仅生产原料药，另外4家可同时生产原料药和制剂。</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"","article_id":"1171059471","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171059471","pubTimestamp":1647530932,"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"3月17日讯，日内瓦药品专利池（Medicines PatentPool, MPP）组织宣布，上海迪赛诺、华海药业、普洛药业、复星医药、九洲药业这五家中国药企进入辉瑞新冠口服药Paxlovid的“特仿","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","PFE":"辉瑞","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4007":"制药"},"translate_title":"Five Chinese pharmaceutical companies entered the \"special imitation\" list of Pfizer's oral medicine in COVID-19","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/7f349bb77dd5d5b7deeba09268e15df7","symbols_score_info":{"PFE":0.9},"content_text":"3月17日讯，日内瓦药品专利池（Medicines PatentPool, MPP）组织宣布，上海迪赛诺、华海药业、普洛药业、复星医药、九洲药业这五家中国药企进入辉瑞新冠口服药Paxlovid的“特仿”名单。在新冠疫情仍被定义为突发公共卫生事件期间，它们可以免专利费生产Paxlovid的核心成分奈玛特韦（nirmatrelvir）。其中，九洲药业仅生产原料药，另外4家可同时生产原料药和制剂。","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":634515032,"gmtCreate":1647567274153,"gmtModify":1676532862958,"author":{"id":"3554347379224535","authorId":"3554347379224535","authorIdStr":"3554347379224535","name":"一分流水","avatar":"https://static.tigerbbs.com/016fad9326a8bae0989a750cdea034c6","vip":1,"crmLevel":6,"crmLevelSwitch":1,"idStr":"3554347379224535"},"htmlText":"事實證明是莊家喊我來接盤的。 以後這樣的帖子假裝看不見。&nbsp;[流淚]&nbsp;","listText":"事實證明是莊家喊我來接盤的。 以後這樣的帖子假裝看不見。&nbsp;[流淚]&nbsp;","text":"事實證明是莊家喊我來接盤的。 以後這樣的帖子假裝看不見。 [流淚]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/634515032","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":634594244,"gmtCreate":1647558987605,"gmtModify":1676532862509,"author":{"id":"3554347379224535","authorId":"3554347379224535","authorIdStr":"3554347379224535","name":"一分流水","avatar":"https://static.tigerbbs.com/016fad9326a8bae0989a750cdea034c6","vip":1,"crmLevel":6,"crmLevelSwitch":1,"idStr":"3554347379224535"},"htmlText":"今天要漲嗎？","listText":"今天要漲嗎？","text":"今天要漲嗎？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/634594244","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9035155013,"gmtCreate":1647557498671,"gmtModify":1676534242753,"author":{"id":"3570864790458781","authorId":"3570864790458781","authorIdStr":"3570864790458781","name":"Yeong","avatar":"https://static.tigerbbs.com/93092185d223c6e53fcfd64303836612","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3570864790458781"},"htmlText":"Y","listText":"Y","text":"Y","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035155013","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035125142,"gmtCreate":1647555786603,"gmtModify":1676534242524,"author":{"id":"3573600397842338","authorId":"3573600397842338","authorIdStr":"3573600397842338","name":"winnieer","avatar":"https://static.tigerbbs.com/3cc26bb14795260a3075fcdafb7a696f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573600397842338"},"htmlText":"😊","listText":"😊","text":"😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035125142","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035167578,"gmtCreate":1647553656854,"gmtModify":1676534242326,"author":{"id":"3564108727353086","authorId":"3564108727353086","authorIdStr":"3564108727353086","name":"Futre","avatar":"https://community-static.tradeup.com/news/912eae14e80f11fedbc3bdb7e10bb6d0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3564108727353086"},"htmlText":"贊👍","listText":"贊👍","text":"贊👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035167578","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9035166517,"gmtCreate":1647552192485,"gmtModify":1676534242240,"author":{"id":"3577393549070429","authorId":"3577393549070429","authorIdStr":"3577393549070429","name":"Youn7276","avatar":"https://static.tigerbbs.com/487c5c26a5e210d6b88adaeaba12329b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577393549070429"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035166517","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035168856,"gmtCreate":1647551673748,"gmtModify":1676534242216,"author":{"id":"4107148386878720","authorId":"4107148386878720","authorIdStr":"4107148386878720","name":"年年虎","avatar":"https://static.itradeup.com/news/70b8112dc8e9c09d8b1c5cb23d97fd96","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4107148386878720"},"htmlText":"😐","listText":"😐","text":"😐","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035168856","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035181933,"gmtCreate":1647535226187,"gmtModify":1676534241877,"author":{"id":"3570366231505984","authorId":"3570366231505984","authorIdStr":"3570366231505984","name":"NCP88","avatar":"https://static.tigerbbs.com/790d2d1f38405c1ee3ec33d3d791763d","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3570366231505984"},"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035181933","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9035132506,"gmtCreate":1647531243654,"gmtModify":1676534241477,"author":{"id":"3586925956765276","authorId":"3586925956765276","authorIdStr":"3586925956765276","name":"VinHun","avatar":"https://static.tigerbbs.com/991b02c8cc322df6d25106ac403eff95","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586925956765276"},"htmlText":"[微笑]&nbsp;[開心]&nbsp;[財迷]&nbsp;[呆住]&nbsp;[呆住]&nbsp;[得意]&nbsp;[得意]&nbsp;","listText":"[微笑]&nbsp;[開心]&nbsp;[財迷]&nbsp;[呆住]&nbsp;[呆住]&nbsp;[得意]&nbsp;[得意]&nbsp;","text":"[微笑] [開心] [財迷] [呆住] [呆住] [得意] [得意]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035132506","repostId":1171059471,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":105,"commentSize":9,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}